Mycobacterium tuberculosis (Mtb) is an obligate human pathogen killing millions of people annually. Treatment for tuberculosis…
pthomsonApril 12, 2021
Dr. Peter Schubert is a Principal Investigator with the UBC Centre for Blood Research (CBR) and a Clinical Associate Professor at…
pthomsonApril 9, 2021
Targeting the epigenome to modulate gene expression programs driving cancer development has emerged as an…
pthomsonApril 8, 2021
Dr. Lakshmi Krishnan explains how increased investment will greatly benefit Canada’s prospects for a future…
pthomsonApril 8, 2021
Doxorubicin is a chemotherapeutic drug used for the treatment of various malignancies; however, patients can…
pthomsonApril 7, 2021
Vancouver's adMare BioInnovations specializes in turning Canada's world-leading research in life sciences - the technology…
pthomsonApril 6, 2021
As UBC begins consultation on its 2030 Climate Action Plan, Moritz Koch, a new postdoctoral…
pthomsonApril 6, 2021
AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration
AbCellera has announced agreements to expand its collaboration with Gilead Sciences, Inc. (Gilead) including a…
pthomsonApril 5, 2021
Fast, accurate and reliable diagnostic tests are critical for controlling the spread of the 2019…
pthomsonApril 5, 2021
